Comirnaty Euroopa Liit - eesti - EMA (European Medicines Agency)

comirnaty

biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vaktsiinid - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. kasutamist see vaktsiin peaks olema kooskõlas ametlike soovitustega.

VANCOMYCIN PHARMASWISS infusioonilahuse pulber Eesti - eesti - Ravimiamet

vancomycin pharmaswiss infusioonilahuse pulber

pharmaswiss ceska republika s.r.o. - vankomütsiin - infusioonilahuse pulber - 1000mg 1tk; 1000mg 10tk

VANCOMYCIN SANDOZ 500 MG infusioonilahuse pulber Eesti - eesti - Ravimiamet

vancomycin sandoz 500 mg infusioonilahuse pulber

sandoz pharmaceuticals d.d. - vankomütsiin - infusioonilahuse pulber - 500mg 5tk; 500mg 10tk; 500mg 1tk

VANCOMYCIN ACTAVIS infusioonilahuse pulber Eesti - eesti - Ravimiamet

vancomycin actavis infusioonilahuse pulber

actavis group ptc ehf. - vankomütsiin - infusioonilahuse pulber - 1000mg 10tk; 1000mg 1tk

VANCOMYCIN SANDOZ 1000 MG infusioonilahuse pulber Eesti - eesti - Ravimiamet

vancomycin sandoz 1000 mg infusioonilahuse pulber

sandoz pharmaceuticals d.d. - vankomütsiin - infusioonilahuse pulber - 1000mg 10tk; 1000mg 5tk

VANCOMYCIN ACTAVIS infusioonilahuse kontsentraadi pulber Eesti - eesti - Ravimiamet

vancomycin actavis infusioonilahuse kontsentraadi pulber

actavis group ptc ehf. - vankomütsiin - infusioonilahuse kontsentraadi pulber - 500mg 1tk; 500mg 10tk

VANCOMYCIN HOSPIRA infusioonilahuse kontsentraadi pulber Eesti - eesti - Ravimiamet

vancomycin hospira infusioonilahuse kontsentraadi pulber

hospira uk limited - vankomütsiin - infusioonilahuse kontsentraadi pulber - 1000mg 10ml 1tk

VANCOMYCIN PFIZER infusioonilahuse kontsentraadi pulber Eesti - eesti - Ravimiamet

vancomycin pfizer infusioonilahuse kontsentraadi pulber

pfizer europe ma eeig - vankomütsiin - infusioonilahuse kontsentraadi pulber - 1000mg 10tk; 1000mg 100tk

VANCOMYCIN PFIZER infusioonilahuse kontsentraadi pulber Eesti - eesti - Ravimiamet

vancomycin pfizer infusioonilahuse kontsentraadi pulber

pfizer europe ma eeig - vankomütsiin - infusioonilahuse kontsentraadi pulber - 500mg 10tk; 500mg 100tk

VANCOMYCIN ACTAVIS infusioonilahuse kontsentraadi pulber Eesti - eesti - Ravimiamet

vancomycin actavis infusioonilahuse kontsentraadi pulber

actavis group ptc ehf. - vankomütsiin - infusioonilahuse kontsentraadi pulber - 1000mg 1000mg 1tk